1. Home
  2. INTS vs NDLS Comparison

INTS vs NDLS Comparison

Compare INTS & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.05

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$15.14

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
NDLS
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
68.7M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
INTS
NDLS
Price
$4.05
$15.14
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$38.00
N/A
AVG Volume (30 Days)
39.3K
26.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$495,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.37
52 Week Low
$0.19
$0.47
52 Week High
$8.06
$15.42

Technical Indicators

Market Signals
Indicator
INTS
NDLS
Relative Strength Index (RSI) 46.47 68.54
Support Level $0.32 $0.59
Resistance Level $8.06 N/A
Average True Range (ATR) 0.24 0.84
MACD 0.08 0.07
Stochastic Oscillator 91.80 91.08

Price Performance

Historical Comparison
INTS
NDLS

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

Share on Social Networks: